Literature DB >> 19933276

Electrostatic interactions between capsid and scaffolding proteins mediate the structural polymorphism of a double-stranded RNA virus.

Irene Saugar1, Nerea Irigoyen, Daniel Luque, José L Carrascosa, José F Rodríguez, José R Castón.   

Abstract

Capsid proteins that adopt distinct conformations constitute a paradigm of the structural polymorphism of macromolecular assemblies. We show the molecular basis of the flexibility mechanism of VP2, the capsid protein of the double-stranded RNA virus infectious bursal disease virus. The initial assembly, a procapsid-like structure, is built by the protein precursor pVP2 and requires VP3, the other infectious bursal disease virus major structural protein, which acts as a scaffold. The pVP2 C-terminal region, which is proteolyzed during virus maturation, contains an amphipathic alpha-helix that acts as a molecular switch. In the absence of VP3, efficient virus-like particle assembly occurs when the structural unit is a VP2-based chimeric protein with an N-terminal-fused His(6) tag. The His tag has a positively charged N terminus and a negatively charged C terminus, both important for virion-like structure assembly. The charge distributions of the VP3 C terminus and His tag are similar. We tested whether the His tag emulates the role of VP3 and found that the presence of a VP3 C-terminal peptide in VP2-based chimeric proteins resulted in the assembly of virus-like particles. We analyzed the electrostatic interactions between these two charged morphogenetic peptides, in which a single residue was mutated to impede the predicted interaction, followed by a compensatory double mutation to rescue electrostatic interactions. The effects of these mutations were monitored by following the virus-like and/or virus-related assemblies. Our results suggest that the basic face of the pVP2 amphipathic alpha-helix interacts with the acidic region of the VP3 C terminus and that this interaction is essential for VP2 acquisition of competent conformations for capsid assembly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933276      PMCID: PMC2823505          DOI: 10.1074/jbc.M109.075994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Genome assembly and particle maturation of the birnavirus infectious pancreatic necrosis virus.

Authors:  Rodrigo A Villanueva; José L Galaz; Juan A Valdés; Matilde M Jashés; Ana María Sandino
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity.

Authors:  Alasdair C Steven; J Bernard Heymann; Naiqian Cheng; Benes L Trus; James F Conway
Journal:  Curr Opin Struct Biol       Date:  2005-04       Impact factor: 6.809

3.  The birnavirus crystal structure reveals structural relationships among icosahedral viruses.

Authors:  Fasséli Coulibaly; Christophe Chevalier; Irina Gutsche; Joan Pous; Jorge Navaza; Stéphane Bressanelli; Bernard Delmas; Félix A Rey
Journal:  Cell       Date:  2005-03-25       Impact factor: 41.582

4.  Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells.

Authors:  G A Ward; C K Stover; B Moss; T R Fuerst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

5.  VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.

Authors:  E Lombardo; A Maraver; J R Castón; J Rivera; A Fernández-Arias; A Serrano; J L Carrascosa; J F Rodriguez
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy.

Authors:  B Böttcher; N A Kiselev; V Y Stel'Mashchuk; N A Perevozchikova; A V Borisov; R A Crowther
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Infectious pancreatic necrosis virus: identification of a VP3-containing ribonucleoprotein core structure and evidence for O-linked glycosylation of the capsid protein VP2.

Authors:  A Hjalmarsson; E Carlemalm; E Everitt
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Proteolytic processing in infectious bursal disease virus: identification of the polyprotein cleavage sites by site-directed mutagenesis.

Authors:  A B Sánchez; J F Rodriguez
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

9.  VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase.

Authors:  Ursula I von Einem; Alexander E Gorbalenya; Horst Schirrmeier; Sven-Erik Behrens; Tobias Letzel; Egbert Mundt
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

10.  The C-terminal domain of the pVP2 precursor is essential for the interaction between VP2 and VP3, the capsid polypeptides of infectious bursal disease virus.

Authors:  Ana Oña; Daniel Luque; Fernando Abaitua; Antonio Maraver; José R Castón; Jose F Rodríguez
Journal:  Virology       Date:  2004-04-25       Impact factor: 3.616

View more
  15 in total

1.  Mechanics of Virus-like Particles Labeled with Green Fluorescent Protein.

Authors:  Johann Mertens; Patricia Bondia; Carolina Allende-Ballestero; José L Carrascosa; Cristina Flors; José R Castón
Journal:  Biophys J       Date:  2018-09-01       Impact factor: 4.033

2.  Host proteolytic activity is necessary for infectious bursal disease virus capsid protein assembly.

Authors:  Nerea Irigoyen; José R Castón; José F Rodríguez
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

3.  Voltage-Dependent Anion Channel 1 Interacts with Ribonucleoprotein Complexes To Enhance Infectious Bursal Disease Virus Polymerase Activity.

Authors:  Chunyan Han; Xiangwei Zeng; Shuai Yao; Li Gao; Lizhou Zhang; Xiaole Qi; Yulu Duan; Bo Yang; Yulong Gao; Changjun Liu; Yanping Zhang; Yongqiang Wang; Xiaomei Wang
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  The RNA-Binding Protein of a Double-Stranded RNA Virus Acts like a Scaffold Protein.

Authors:  Carlos P Mata; Johann Mertens; Juan Fontana; Daniel Luque; Carolina Allende-Ballestero; David Reguera; Benes L Trus; Alasdair C Steven; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

Authors:  Elena Pascual; Carlos P Mata; Josué Gómez-Blanco; Noelia Moreno; Juan Bárcena; Esther Blanco; Ariel Rodríguez-Frandsen; Amelia Nieto; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

6.  Infectious Bursal Disease Virus Hijacks Endosomal Membranes as the Scaffolding Structure for Viral Replication.

Authors:  María Cecilia Gimenez; Flavia Adriana Zanetti; Mauricio R Terebiznik; María Isabel Colombo; Laura Ruth Delgui
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Why large icosahedral viruses need scaffolding proteins.

Authors:  Siyu Li; Polly Roy; Alex Travesset; Roya Zandi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

8.  The VP3 factor from viruses of Birnaviridae family suppresses RNA silencing by binding both long and small RNA duplexes.

Authors:  Adrian Valli; Idoia Busnadiego; Varvara Maliogka; Diego Ferrero; José R Castón; José Francisco Rodríguez; Juan Antonio García
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  A protein with simultaneous capsid scaffolding and dsRNA-binding activities enhances the birnavirus capsid mechanical stability.

Authors:  Johann Mertens; Santiago Casado; Carlos P Mata; Mercedes Hernando-Pérez; Pedro J de Pablo; José L Carrascosa; José R Castón
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

Review 10.  Physical virology: From virus self-assembly to particle mechanics.

Authors:  Pedro Buzón; Sourav Maity; Wouter H Roos
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.